Literature DB >> 8535152

Purification, functional characterization, and crystallization of the ligand binding domain of the retinoid X receptor.

W Bourguet1, M Ruff, D Bonnier, F Granger, M Boeglin, P Chambon, D Moras, H Gronemeyer.   

Abstract

The ligand binding domain (LBD) of the human retinoid X receptor alpha (hRXR alpha) was overproduced in Escherichia coli and purified to more than 95% purity and functional homogeneity. Circular dichroism spectra of the purified RXR alpha LBD indicated that the protein was composed predominantly of alpha-helical structures and coils. Crystals were grown from ammonium citrate using the vapor diffusion method against a reservoir containing 100 mM Pipes (pH 7.0) and 1.5 M ammonium citrate. They belong to the hexagonal space group P6(3)22 with unit cell parameters a = b = 110.8 A and c = 109.9 A, alpha = beta = 90 degrees, gamma = 120 degrees, and they diffract X rays to a resolution limit of 2.5 A using synchrotron radiation. The asymmetric unit of the crystals contains one molecule with a solvent content of approximately 55% and a Vm value of 3.6 A3/dalton.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535152     DOI: 10.1006/prep.1995.1079

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  4 in total

1.  A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.

Authors:  V Vivat; C Zechel; J M Wurtz; W Bourguet; H Kagechika; H Umemiya; K Shudo; D Moras; H Gronemeyer; P Chambon
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

2.  Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site.

Authors:  Liqun Chen; Zhi-Gang Wang; Alexander E Aleshin; Fan Chen; Jiebo Chen; Fuquan Jiang; Gulimiran Alitongbieke; Zhiping Zeng; Yue Ma; Mingfeng Huang; Hu Zhou; Gregory Cadwell; Jian-Feng Zheng; Pei-Qiang Huang; Robert C Liddington; Xiao-kun Zhang; Ying Su
Journal:  Chem Biol       Date:  2014-04-03

3.  Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.

Authors:  Liqun Chen; Alexander E Aleshin; Gulimiran Alitongbieke; Yuqi Zhou; Xindao Zhang; Xiaohong Ye; Mengjie Hu; Gaoang Ren; Ziwen Chen; Yue Ma; Duo Zhang; Shuai Liu; Weiwei Gao; Lijun Cai; Lingjuan Wu; Zhiping Zeng; Fuquan Jiang; Jie Liu; Hu Zhou; Gregory Cadwell; Robert C Liddington; Ying Su; Xiao-Kun Zhang
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

4.  The role of androgen receptor mutations in prostate cancer progression.

Authors:  G N Brooke; C L Bevan
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.